Clinical Trial Update: Immunoreactivity to Cetuximab in Cancer Patients

View source ↗

Summary

This completed clinical trial evaluated immunoreactivity to cetuximab in patients with colorectal cancer and head and neck cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Head and Neck Cancer

Drugs mentioned

• ERBITUX (cetuximab)

Snippet

Sponsor: Vanderbilt-Ingram Cancer Center | Conditions: Colorectal Cancer, Head and Neck Cancer | Status: COMPLETED